BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 18401830)

  • 21. Different expression of protein kinase A (PKA) regulatory subunits in cortisol-secreting adrenocortical tumors: relationship with cell proliferation.
    Mantovani G; Lania AG; Bondioni S; Peverelli E; Pedroni C; Ferrero S; Pellegrini C; Vicentini L; Arnaldi G; Bosari S; Beck-Peccoz P; Spada A
    Exp Cell Res; 2008 Jan; 314(1):123-30. PubMed ID: 17904549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling.
    Iliopoulos D; Bimpaki EI; Nesterova M; Stratakis CA
    Cancer Res; 2009 Apr; 69(8):3278-82. PubMed ID: 19351815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor 2 (IGF2) expression in adrenocortical disease due to PRKAR1A mutations compared to other benign adrenal tumors.
    Nadella KS; Berthon A; Almeida MQ; Levy I; Faucz FR; Stratakis CA
    Endocrine; 2021 Jun; 72(3):823-834. PubMed ID: 33420948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenal pathophysiology: lessons from the Carney complex.
    Groussin L; Cazabat L; René-Corail F; Jullian E; Bertherat J
    Horm Res; 2005; 64(3):132-9. PubMed ID: 16192737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A.
    Shi Z; Henwood MJ; Bannerman P; Batista D; Horvath A; Guttenberg M; Stratakis CA; Grimberg A
    Growth Horm IGF Res; 2007 Apr; 17(2):113-21. PubMed ID: 17280861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors.
    Stratakis CA
    Mol Cell Endocrinol; 2009 Mar; 300(1-2):152-7. PubMed ID: 19063937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.
    Hofland J; de Herder WW; Derks L; Hofland LJ; van Koetsveld PM; de Krijger RR; van Nederveen FH; Horvath A; Stratakis CA; de Jong FH; Feelders RA
    Eur J Endocrinol; 2013 Jan; 168(1):67-74. PubMed ID: 23065993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An immortalized human cell line bearing a PRKAR1A-inactivating mutation: effects of overexpression of the wild-type Allele and other protein kinase A subunits.
    Nesterova M; Bossis I; Wen F; Horvath A; Matyakhina L; Stratakis CA
    J Clin Endocrinol Metab; 2008 Feb; 93(2):565-71. PubMed ID: 18056771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implications.
    London E; Rothenbuhler A; Lodish M; Gourgari E; Keil M; Lyssikatos C; de la Luz Sierra M; Patronas N; Nesterova M; Stratakis CA
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E303-10. PubMed ID: 24248186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
    de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
    Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds.
    Groussin L; Horvath A; Jullian E; Boikos S; Rene-Corail F; Lefebvre H; Cephise-Velayoudom FL; Vantyghem MC; Chanson P; Conte-Devolx B; Lucas M; Gentil A; Malchoff CD; Tissier F; Carney JA; Bertagna X; Stratakis CA; Bertherat J
    J Clin Endocrinol Metab; 2006 May; 91(5):1943-9. PubMed ID: 16464939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
    Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer.
    Anselmo J; Medeiros S; Carneiro V; Greene E; Levy I; Nesterova M; Lyssikatos C; Horvath A; Carney JA; Stratakis CA
    J Clin Endocrinol Metab; 2012 Feb; 97(2):351-9. PubMed ID: 22112814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families.
    Pereira AM; Hes FJ; Horvath A; Woortman S; Greene E; Bimpaki E; Alatsatianos A; Boikos S; Smit JW; Romijn JA; Nesterova M; Stratakis CA
    J Clin Endocrinol Metab; 2010 Jan; 95(1):338-42. PubMed ID: 19915019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein kinase A alterations in adrenocortical tumors.
    Espiard S; Ragazzon B; Bertherat J
    Horm Metab Res; 2014 Nov; 46(12):869-75. PubMed ID: 25105543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenocorticotropic hormone-independent Cushing's syndrome.
    Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
    Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features of Bloom syndrome and function of the causative gene, BLM helicase.
    Kaneko H; Kondo N
    Expert Rev Mol Diagn; 2004 May; 4(3):393-401. PubMed ID: 15137905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary pigmented nodular adrenocortical disease and Cushing's syndrome.
    Horvath A; Stratakis C
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1238-44. PubMed ID: 18209861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and molecular genetics of primary pigmented nodular adrenocortical disease.
    Sandrini F; Stratakis C
    Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):637-41. PubMed ID: 15761532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case report of familial Carney complex due to novel frameshift mutation c.597del C (p.Phe200LeufsX6) in PRKAR1A.
    Sasaki A; Horikawa Y; Suwa T; Enya M; Kawachi S; Takeda J
    Mol Genet Metab; 2008 Nov; 95(3):182-7. PubMed ID: 18760947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.